PET Imaging of VMAT2 with the Novel Radioligand [


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
15 12 2021
Historique:
pubmed: 24 11 2021
medline: 27 1 2022
entrez: 23 11 2021
Statut: ppublish

Résumé

The vesicular monoamine transporter type 2 (VMAT2) is believed to be responsible for the uptake of monoamines into the vesicles of the synaptic terminals. Two VMAT2 radioligands [

Identifiants

pubmed: 34813272
doi: 10.1021/acschemneuro.1c00651
pmc: PMC8678981
doi:

Substances chimiques

Fluorine Radioisotopes 0
Radiopharmaceuticals 0
Vesicular Monoamine Transport Proteins 0
Tetrabenazine Z9O08YRN8O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4580-4586

Références

J Nucl Med. 2010 Feb;51(2):223-8
pubmed: 20080893
Rev Esp Med Nucl. 2008 Jan-Feb;27(1):13-21
pubmed: 18208777
Adv Drug Deliv Rev. 2019 Jan 15;139:16-31
pubmed: 31378283
Brain. 2003 Dec;126(Pt 12):2648-55
pubmed: 12937076
N Engl J Med. 2013 Feb 7;368(6):543-50
pubmed: 23363473
FEBS Lett. 1993 Mar 8;318(3):325-30
pubmed: 8095030
Hum Mol Genet. 2006 Jan 15;15(2):299-305
pubmed: 16339215
Pflugers Arch. 2004 Feb;447(5):636-40
pubmed: 12827358
Nature. 2011 Aug 10;476(7359):152
pubmed: 21833072
Appl Radiat Isot. 2002 Sep;57(3):335-42
pubmed: 12201139
Nature. 2012 Oct 11;490(7419):262-6
pubmed: 23034651
J Histochem Cytochem. 2003 Aug;51(8):1027-40
pubmed: 12871984
Nucl Med Biol. 2010 Nov;37(8):869-71
pubmed: 21055616
Talanta. 2020 Nov 1;219:121220
pubmed: 32887121
Eur J Neurol. 2015 May;22(5):845-52, e59-60
pubmed: 25690304
Nature. 1998 Oct 1;395(6701):451-2
pubmed: 9774100
Psychopharmacology (Berl). 1993;113(2):149-56
pubmed: 7855175
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1639-50
pubmed: 19437012
Nucl Med Biol. 2021 Jan;92:38-42
pubmed: 32122751
Lab Anim Sci. 1997 Dec;47(6):580-5
pubmed: 9433693
J Nucl Med. 2009 Mar;50(3):382-9
pubmed: 19223416
Nucl Med Biol. 2010 Apr;37(3):357-63
pubmed: 20346875
Nat Med. 2001 Oct;7(10):1144-50
pubmed: 11590439
Brain Res Mol Brain Res. 1996 Feb;36(1):157-62
pubmed: 9011752
EJNMMI Res. 2011 Dec 05;1(1):33
pubmed: 22214308
Nucl Med Biol. 2006 Aug;33(6):685-94
pubmed: 16934687
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):68-82
pubmed: 22460161
Neuropharmacology. 2014 Jan;76 Pt A:146-55
pubmed: 23978383
Nucl Med Biol. 2010 Jan;37(1):3-8
pubmed: 20122661
Synapse. 2004 Aug;53(2):57-67
pubmed: 15170818
PET Clin. 2010 Jan;5(1):75-82
pubmed: 27157484

Auteurs

Sangram Nag (S)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Mahabuba Jahan (M)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Miklós Tóth (M)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Ryuji Nakao (R)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Andrea Varrone (A)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Christer Halldin (C)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH